# Study to Compare Gabapentin to Tramadol in Children With Chronic Neuropathic or Mixed Pain

> **NCT02722603** · PHASE3 · TERMINATED · sponsor: **Pharmaceutical Research Management srl** · enrollment: 2 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** gabapentin
- **DRUG:** tramadol
- **OTHER:** placebo tramadol
- **OTHER:** placebo gabapentin

## Key facts

- **NCT ID:** NCT02722603
- **Lead sponsor:** Pharmaceutical Research Management srl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-12
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-06-18
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** The study was early terminated due to insufficient recruitment
- **Last updated:** 2019-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02722603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02722603, "Study to Compare Gabapentin to Tramadol in Children With Chronic Neuropathic or Mixed Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02722603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*